Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
Objectives: To access the cost of illness, quality of life and work limitation in active ankylosing spondylitis (AS) patients using adalimumab in China.Methods: A prospective study was performed in 91 patients with active AS in China. Adult patients (aged ≥ 18 years) fulfilled the 1984 New York modi...
Saved in:
Main Authors: | Liudan Tu (Author), Ya Xie (Author), Zetao Liao (Author), Yutong Jiang (Author), Qing Lv (Author), Shuangyan Cao (Author), Qiujing Wei (Author), Jieruo Gu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab
by: Yutong Jiang, et al.
Published: (2021) -
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study
by: Jialing Wu, et al.
Published: (2020) -
Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
by: M. Fernandes, et al.
Published: (2011) -
Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
by: Xiaoliang Ding, et al.
Published: (2020) -
Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study
by: Min Xiao, et al.
Published: (2019)